Evofem Biosciences Inc (EVFM) financials · rev $3.5M
Evofem Biosciences Inc (EVFM) rev $3.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $20.2M | $19.4M |
| Cost of Revenue | $4.6M | $3.8M |
| Gross Profit | $15.6M | $15.5M |
| Operating Income | $3.4M | -$7.7M |
| Net Income | $391.0K | -$8.9M |
| EPS (Diluted) | $0.00 | $-0.12 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $20.3M | $23.8M |
| Current Assets | $15.3M | $13.6M |
| Cash & Equivalents | $578.0K | $741.0K |
| Inventory | $1.1M | $1.6M |
| PP&E | $418.0K | $458.0K |
| Total Liabilities | $89.7M | $90.3M |
| Current Liabilities | $84.8M | $80.4M |
| Short-term Debt | $147.0K | $135.0K |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | -$74.3M | -$71.3M |
| Retained Earnings | -$897.4M | -$897.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$2.0M | -$3.9M |
| CapEx | $5.0K | $14.0K |
| Investing Cash Flow | -$62.0K | -$569.0K |
| Financing Cash Flow | $1.9M | $4.6M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$163.0K | $161.0K |
| Free Cash Flow | -$2.0M | -$3.9M |
FAQ
What is EVFM P/E and revenue?
Evofem Biosciences Inc (EVFM) rev $3.5M.
What is EVFM revenue?
Evofem Biosciences Inc last cached revenue is $20.2M (FY2025).
Is EVFM profitable?
Evofem Biosciences Inc last cached net income is $391.0K.
What are EVFM total assets?
Evofem Biosciences Inc last cached total assets are $20.3M.
What is EVFM free cash flow?
Evofem Biosciences Inc last cached free cash flow is -$2.0M.
Not investment advice. Cached statements, not a live tape.